Trial Profile
Prospective, randomized, open-label, clinical trial comparing the effects of sitagliptin and voglibose on postprandial glucose/lipids metabolism and endothelial function in diabetic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Voglibose (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 17 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 03 Jun 2011 New trial record